Gag. Gag-Gag. TSG101 Nedd4. Two-Hybrid HIV Gag. Two-Hybrid. Two-Hybrid

Similar documents
Received 26 August 2008; revised 10 October 2008; accepted 21 October Available online 7 November Edited by Ivan Sadowski

Recombinant Protein Expression Retroviral system

Viral Vectors In The Research Laboratory: Just How Safe Are They? Dawn P. Wooley, Ph.D., SM(NRM), RBP, CBSP

Novel Postentry Inhibitor of Human Immunodeficiency Virus Type 1 Replication Screened by Yeast Membrane-Associated Two-Hybrid System

VIROLOGY. Engineering Viral Genomes: Retrovirus Vectors

Fayth K. Yoshimura, Ph.D. September 7, of 7 HIV - BASIC PROPERTIES

HIV. Perspectives of Anti-HIV Research

Retroviruses. ---The name retrovirus comes from the enzyme, reverse transcriptase.

Supplementary Fig. S1. Schematic diagram of minigenome segments.

Supplementary Figure 1. SC35M polymerase activity in the presence of Bat or SC35M NP encoded from the phw2000 rescue plasmid.

Plasmid-Driven Formation of Influenza Virus-Like Particles

7.012 Problem Set 6 Solutions

Reverse Genetics of RNA Viruses

October 26, Lecture Readings. Vesicular Trafficking, Secretory Pathway, HIV Assembly and Exit from Cell

Fayth K. Yoshimura, Ph.D. September 7, of 7 RETROVIRUSES. 2. HTLV-II causes hairy T-cell leukemia

~Lentivirus production~

Supplemental Materials and Methods Plasmids and viruses Quantitative Reverse Transcription PCR Generation of molecular standard for quantitative PCR

The accumulation of influenza A virus segment 7 spliced mrnas is regulated by the NS1 protein

L I F E S C I E N C E S

VIRUSES. 1. Describe the structure of a virus by completing the following chart.

Introduction retroposon

Biol115 The Thread of Life"

Supplementary information. MARCH8 inhibits HIV-1 infection by reducing virion incorporation of envelope glycoproteins

CHARACTERIZING THE ROLE OF N TERMINUS OF INFLUENZA A NUCLEOPROTEIN FOR LOCATION AND VIRAL RNP ACTIVITY

Overview: Chapter 19 Viruses: A Borrowed Life

Transcription and RNA processing

Herpesviruses. Virion. Genome. Genes and proteins. Viruses and hosts. Diseases. Distinctive characteristics

Materials and Methods , The two-hybrid principle.

NC Pol RNA RNA DNA D C T RNA. retroviruses/ Gag Pol Env. E/psi. E/psi RNA. MA CA NC MA Env CA 2-4

HIV INFECTION: An Overview

HIV transcription, Tat transactivation mrna processing and latency

Name Section Problem Set 6

Under the Radar Screen: How Bugs Trick Our Immune Defenses

Towards a block and lock strategy: LEDGINs hamper the establishment of a reactivation competent HIV reservoir.

LESSON 4.4 WORKBOOK. How viruses make us sick: Viral Replication

HIV-1 Virus-like Particle Budding Assay Nathan H Vande Burgt, Luis J Cocka * and Paul Bates

Hands-on Activity Viral DNA Integration. Educator Materials

Feb 11, Gene Therapy. Sam K.P. Kung Immunology Rm 417 Apotex Center

Polyomaviridae. Spring

Ralf Wagner Paul-Ehrlich-Institut

Role of ESCRT-I in Retroviral Budding

Section 6. Junaid Malek, M.D.

RAPID COMMUNICATION. Canine Cyclin T1 Rescues Equine Infectious Anemia Virus Tat Trans-Activation in Human Cells

Influenza viruses. Virion. Genome. Genes and proteins. Viruses and hosts. Diseases. Distinctive characteristics

19 Viruses BIOLOGY. Outline. Structural Features and Characteristics. The Good the Bad and the Ugly. Structural Features and Characteristics

VIRAL TITER COUNTS. The best methods of measuring infectious lentiviral titer

Supplementary information

HIV & AIDS: Overview

Human Immunodeficiency Virus

Julianne Edwards. Retroviruses. Spring 2010

Chapter 13 Viruses, Viroids, and Prions. Biology 1009 Microbiology Johnson-Summer 2003

VIRUSES AND CANCER Michael Lea

Certificate of Analysis

Hepatitis B Antiviral Drug Development Multi-Marker Screening Assay

Cellular MicroRNA and P Bodies Modulate Host-HIV-1 Interactions. 指導教授 : 張麗冠博士 演講者 : 黃柄翰 Date: 2009/10/19

Chapter 19: Viruses. 1. Viral Structure & Reproduction. 2. Bacteriophages. 3. Animal Viruses. 4. Viroids & Prions

Nature Immunology doi: /ni Supplementary Figure 1. Raf-1 inhibition does not affect TLR4-induced type I IFN responses.

Viral structure م.م رنا مشعل

L I F E S C I E N C E S

Balanced splicing at the Tat-specific HIV-1 3 ss A3 is critical for HIV-1 replication

HUMAN IMMUNODEFICIENCY VIRUS

HIV 101: Fundamentals of HIV Infection

Genome of Hepatitis B Virus. VIRAL ONCOGENE Dr. Yahwardiah Siregar, PhD Dr. Sry Suryani Widjaja, Mkes Biochemistry Department

AP Biology. Viral diseases Polio. Chapter 18. Smallpox. Influenza: 1918 epidemic. Emerging viruses. A sense of size

HOST-PATHOGEN CO-EVOLUTION THROUGH HIV-1 WHOLE GENOME ANALYSIS

Transcription and RNA processing


INI1/hSNF5-interaction defective HIV-1 IN mutants exhibit impaired particle morphology, reverse transcription and integration in vivo

Virology Journal. Open Access. Abstract. BioMed Central

DNA context and promoter activity affect gene expression in lentiviral vectors

Unidirectional RNA polymerase I polymerase II transcription system for the generation of influenza A virus from eight plasmids

Chapter 19: Viruses. 1. Viral Structure & Reproduction. What exactly is a Virus? 11/7/ Viral Structure & Reproduction. 2.

Medical Virology. Herpesviruses, Orthomyxoviruses, and Retro virus. - Herpesviruses Structure & Composition: Herpesviruses

Lecture Readings. Vesicular Trafficking, Secretory Pathway, HIV Assembly and Exit from Cell

Viral Genetics. BIT 220 Chapter 16

Hierarchy among Viral RNA (vrna) Segments in Their Role in vrna Incorporation into Influenza A Virions

SUPPLEMENTARY INFORMATION

Endogenous Retroviral elements in Disease: "PathoGenes" within the human genome.

ISG15 sirna # Ctrl sirna+ifn+wt. Virus titer (Pfu/ml) hours post infection. d USP18 sirna #2 IFN

SUPPLEMENTARY INFORMATION

ACQUIRED IMMUNODEFICIENCY SYNDROME AND ITS OCULAR COMPLICATIONS

Soft Agar Assay. For each cell pool, 100,000 cells were resuspended in 0.35% (w/v)

Oncolytic Adenovirus Complexes Coated with Lipids and Calcium Phosphate for Cancer Gene Therapy

ZASC1 Stimulates HIV-1 Transcription Elongation by Recruiting P-TEFb and TAT to the LTR Promoter

Packaging and Abnormal Particle Morphology

Running Head: AN UNDERSTANDING OF HIV- 1, SYMPTOMS, AND TREATMENTS. An Understanding of HIV- 1, Symptoms, and Treatments.

De novo replication of the influenza virus RNA genome is regulated by DNA replicative helicase, MCM

Overview of virus life cycle

Some living things are made of ONE cell, and are called. Other organisms are composed of many cells, and are called. (SEE PAGE 6)

Chapter 6- An Introduction to Viruses*

Unexpected complexity in the interference activity of a cloned influenza defective interfering RNA

MCB130 Midterm. GSI s Name:

Certificate of Analysis

5/6/17. Diseases. Disease. Pathogens. Domain Bacteria Characteristics. Bacteria Viruses (including HIV) Pathogens are disease-causing organisms

Reverse transcription and integration

7.012 Quiz 3 Answers

Viruses Tomasz Kordula, Ph.D.

Journal of Biology. BioMed Central

FIG S1 Examination of eif4b expression after virus infection. (A) A549 cells

Fig. 1: Schematic diagram of basic structure of HIV

Transcription:

CytoTrap HIV Gag AnnexinA2 AUP1 AUP1 HIV AUP1 N Gag CytoTrap Gag-Gag TSG101 Nedd4 Two-Hybrid Two-Hybrid HIVGag Gag Two-Hybrid

HIV Gag Gag HIV Two-Hybrid CytoTrap cdna Gag Gag CytoTrap Gag CytoTrap Gag-Gag Gag-Gag HIV CytoTrap Gag CytoTrap Stratagene cdna pmyr HIV-1 Gag psos Saccharomyces cerevisiae cdc25ha MATa ura3-52 his3-200 ade2-101 lys2-801 trp1-901 leu2-3 112 cdc25-2 Gal + 1 CytoTrap Gag-Gag HIV-1 Gag pmyr psos Gag/pMyr Gag/pSOS cdc25ha Gag-Gag cdc25ha OD 600 =0.1 Enamine OD 630 DNA transfection cdna AUP1 isoform1 isoform 2 PCR pcdna3-flag-hisc HIV-1 cdna pnl432 Lipofectamine 2000Invitrogen HeLa, 293T cotransfection Gag-GFP pnl432 derivative RT-PCR : HeLa, 293T T : Jurkat, CEM174, SupT1 : U937 RNA oligo dt+random primers PCR cdna Clontech SDS-PAGE Western blotting HIV-1 p24ca FLAG 3.7% FLAG TGN, PDI, CD63 HIV HIV-1 p24 capture ELISA KitZeptometrix CytoTrap Gag pmyr 800,000 3 3 cgmp Annexin A2AUP1 cgmp RAS Gag Annexin A2 Gag HIV AUP1 AUP1 mrna AUP1 mrna isoform 1unspliced form isoform 2spliced formisoform 1 N

AUP1 mrna isoform 2 isoform isoform 2 isoform AUP1 HIV-1 AUP1 isoform 2 AUP1 C N isoform 2 CD63 TGN46 N PDI HIV-1 Gag isoform 2 C Gag N Gag AUP1 HIV-1 AUP1 HIV-1 cdna HeLa isoform 2 isoform 1 isoform 1 N C N HIV C HIV AUP1 N 40 CytoTrap Gag-Gag CytoTrap Gag-Gag 96 high-throughput format 20,000 IC 50 Gag-Gag S. Kawada, T. Goto, H. Haraguchi, A. Ono, & Y. Morikawa. Dominant negative inhibition of human immunodeficiency virus particle production by the non-myristoylated form of Gag. J. Virol. 82: 4384-4399 (2008) E. Urano, S. Shimizu, Y. Futahashi, M. Hamatake, Y. Morikawa, N. Takahashi, H. Fukazawa, N. Yamamoto, & J. Komano.

Cyclin K/CPR4 inhibits primate lentiviral replication by inactivating Tat/P-TEFb-dependent LTR transcription. AIDS 22: 1081-1083 (2008) S. Yamayoshi, T. Noda, H. Ebihara, H. Goto, Y. Morikawa, I. S. Lukashevich, G. Neumann, H. Feldmann, & Y. Kawaoka. Ebola virus matrix VP40 protein uses the COPII transport system for its intracellular transport. Cell Host Microbe 3: 168-177 (2008) A. Ryo, N. Tsurutani, K. Ohba, R. Kimura, J. Komano, M. Nishi, H. Soeda, S. Hattori, K. Perrem, M. Yamamoto, J. Chiba, J. Mimaya, K. Yoshimura, S. Matsushita, M. Honda, A. Yoshimura, T. Sawasaki, I. Aoki, Y. Morikawa, & N. Yamamoto. SOCS1 is an inducible host factor during HIV-1 infection and regulates the intracellular trafficking and stability of HIV-1 Gag. Proc. Natl. Acad. Sci. USA 105: 294-299 (2008) E. Urano, T. Aoki, Y. Futahashi, T. Murakami, Y. Morikawa, N. Yamamoto, & J. Komano. Substitution of the myristoylation signal of human immunodeficiency virus type 1 Pr55 Gag with the phopholipase C delta 1 pleckstrin homology domain results in infectious pseudovirion production. J. Gen. Virol. (in press) E. Urano, Y. Kariya, Y. Futahashi, R. Ichikawa, M. Hamatake, H. Fukazawa, Y. Morikawa, T. Yoshida, Y. Koyanagi, N. Yamamoto, & J. Komano. Identification of the P-TEFb complex-interacting domain of Brd4 as an inhibitor of HIV-1 replication by functional cdna library screening in MT-4 cells. FEBS Let 582: 4053-4058 (2008) Y. Morikawa, T. Goto, D. Yasuoka, F. Momose, & T. Matano. Defect of Human Immunodeficiency Virus Type 2 Gag Assembly in Saccharomyces cerevisiae. J. Virol. 81: 9911-9921 (2007) HIV 52:1181-1186 (2007) F. Momose, Y. Kikuchi, K. Komase, & Y. Morikawa. Visualization of microtubulemediated transport of influenza viral progeny ribonucleoprotein. Microbes Infect. 9: 1422-1433 (2007) T. Naito, F. Momose, A.Kawaguchi, & K. Nagata. Involvement of Hsp90 in assembly and nuclear import of influenza virus RNA polymerase subunits. J. Virol. 81: 1339-1349 (2007) S. Sakuragi, J. Sakuragi, Y. Morikawa, & T. Shioda. Development of a rapid and convenient method for the quantitation of HIV-1 budding. Microbes Infect. 8: 1875-1881 (2006) 56: 9-16 (2006) E. Urano, Y. Kariya, Y. Futahashi, M. Hamatake, Y. Morikawa, T. Yoshida, Y. Koyanagi, N. Yamamoto, & J. Komano. Identification of the carboxy-terminal domain of chromatin-associated transcriptional activator bromodomain containing 4 as a specific silencer of HIV-1 replication. CSH Retrovirus Meeting2008 5 NY DNA J/ HSP40 Co-chaperonine family HIV-1 56 2008 10 HIV-1 Gag-Pol 56 2008 10 RNP 56 2008 10 HIV 56 2008 10 RNP 56 2008 10 AUP1 HIV 56 2008 10 RNP 31 / 81 2008 12 E. Urano, S. Shimizu, M. Hamatake, Y. Morikawa, & J. Komano. Upregulating expression of cyclin K/CPR4 limits the replication of HIV-1. CSH Retrovirus Meeting2007 5 NY HIV 55

2007 10 Gag - 55 2007 10 HIV-1 Gag-Pol 55 2007 10 NP RNP 55 2007 10 HRS Gag 30 / 80 2007 12 Gag-Pol 30/80 200712 vrnp 30 / 80 2007 12 N. Tsurutani, T. Goto, I. S. Ohno, & Y. Morikawa. Identification of host cellular machinery for HIV-1 Gag trafficking. CSH Retrovirus Meeting2006 NY N. Tsurutani, T. Goto, I. S. Ohno, & Y. Morikawa. Identification of host cellular machinery for HIV-1 Gag trafficking. ASCB Meeting2006 AL 21 F. Momose, A. Kawaguchi, A. Iwamatsu, Y. Morikawa & K. Nagata. Stimulation of influenza virus RNA synthesis by a host factor RAF-2 that is bound to viral nucleoprotein and the genome RNA. 13ICNSV2006 22 HIV Gag 54 2006 11 23 HIV Gag 54 2006 11 24 RAF-2p36 RNP 54 2006 10 25 Y. Morikawa. Dominant negative inhibition of HIV particle production by the nonmyristoylated form of Gag. 20 2006